Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Female Contraceptive Market Status and Forecast (2016-2027)
  • 1.3.2 Global Female Contraceptive Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Female Contraceptive Supply by Company

• 2.1 Global Female Contraceptive Sales Volume by Company
• 2.2 Global Female Contraceptive Sales Value by Company
• 2.3 Global Female Contraceptive Price by Company
• 2.4 Female Contraceptive Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Female Contraceptive Market Status by Category

• 3.1 Female Contraceptive Category Introduction
  • 3.1.1 Female Contraceptive Devices
  • 3.1.2 Female Contraceptive Drugs
• 3.2 Global Female Contraceptive Market by Category
  • 3.2.1 Global Female Contraceptive Sales Volume by Category (2016-2021)
  • 3.2.2 Global Female Contraceptive Sales Value by Category (2016-2021)
  • 3.2.3 Global Female Contraceptive Price by Category (2016-2021)
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Female Contraceptive Market Status by End User/Segment

• 4.1 Female Contraceptive Segment by End User/Segment
  • 4.1.1 Online Stores
  • 4.1.2 Retail Outlets
• 4.2 Global Female Contraceptive Market by End User/Segment
  • 4.2.1 Global Female Contraceptive Sales Volume by End User/Segment (2016-2021)
  • 4.2.2 Global Female Contraceptive Sales Value by End User/Segment (2016-2021)
  • 4.2.3 Global Female Contraceptive Price by End User/Segment (2016-2021)
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Female Contraceptive Market Status by Region

• 5.1 Global Female Contraceptive Market by Region
  • 5.1.1 Global Female Contraceptive Sales Volume by Region
  • 5.1.2 Global Female Contraceptive Sales Value by Region
• 5.2 North America Female Contraceptive Market Status
• 5.3 Europe Female Contraceptive Market Status
• 5.4 Asia Pacific Female Contraceptive Market Status
• 5.5 Central & South America Female Contraceptive Market Status
• 5.6 Middle East & Africa Female Contraceptive Market Status

6 North America Female Contraceptive Market Status

• 6.1 North America Female Contraceptive Market by Country
  • 6.1.1 North America Female Contraceptive Sales Volume by Country (2016-2021)
  • 6.1.2 North America Female Contraceptive Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Female Contraceptive Market Status

• 7.1 Europe Female Contraceptive Market by Country
  • 7.1.1 Europe Female Contraceptive Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Female Contraceptive Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Female Contraceptive Market Status

• 8.1 Asia Pacific Female Contraceptive Market by Country
  • 8.1.1 Asia Pacific Female Contraceptive Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Female Contraceptive Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Female Contraceptive Market Status

• 9.1 Central & South America Female Contraceptive Market by Country
  • 9.1.1 Central & South America Female Contraceptive Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Female Contraceptive Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Female Contraceptive Market Status

• 10.1 Middle East & Africa Female Contraceptive Market by Country
  • 10.1.1 Middle East & Africa Female Contraceptive Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Female Contraceptive Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Female Contraceptive Manufacturing Cost Analysis
• 11.5 Female Contraceptive Sales Channel and Distributors Analysis
  • 11.5.1 Female Contraceptive Sales Channel
  • 11.5.2 Female Contraceptive Distributors
• 11.6 Female Contraceptive Downstream Major Buyers

12 Global Female Contraceptive Market Forecast by Category and by End User/Segment

• 12.1 Global Female Contraceptive Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Female Contraceptive Forecast by Category
  • 12.2.1 Global Female Contraceptive Sales Volume Forecast by Category
  • 12.2.2 Global Female Contraceptive Sales Value Forecast by Category
  • 12.2.3 Global Female Contraceptive Price Forecast by Category
• 12.3 Global Female Contraceptive Forecast by End User/Segment
  • 12.3.1 Global Female Contraceptive Sales Volume Forecast by End User/Segment
  • 12.3.2 Global Female Contraceptive Sales Value Forecast by End User/Segment
  • 12.3.3 Global Female Contraceptive Price Forecast by End User/Segment

13 Global Female Contraceptive Market Forecast by Region/Country

• 13.1 Global Female Contraceptive Market Forecast by Region (2022-2027)
  • 13.1.1 Global Female Contraceptive Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Female Contraceptive Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Teva Pharmaceuticals
  • 14.1.1 Company Information
  • 14.1.2 Female Contraceptive Product Introduction
  • 14.1.3 Teva Pharmaceuticals Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Reckitt Benckiser
  • 14.2.1 Company Information
  • 14.2.2 Female Contraceptive Product Introduction
  • 14.2.3 Reckitt Benckiser Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Pfizer
  • 14.3.1 Company Information
  • 14.3.2 Female Contraceptive Product Introduction
  • 14.3.3 Pfizer Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Okamoto Industries
  • 14.4.1 Company Information
  • 14.4.2 Female Contraceptive Product Introduction
  • 14.4.3 Okamoto Industries Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Merck
  • 14.5.1 Company Information
  • 14.5.2 Female Contraceptive Product Introduction
  • 14.5.3 Merck Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Lupin Pharmaceuticals
  • 14.6.1 Company Information
  • 14.6.2 Female Contraceptive Product Introduction
  • 14.6.3 Lupin Pharmaceuticals Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Janssen Pharmaceuticals
  • 14.7.1 Company Information
  • 14.7.2 Female Contraceptive Product Introduction
  • 14.7.3 Janssen Pharmaceuticals Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Fuji Latex
  • 14.8.1 Company Information
  • 14.8.2 Female Contraceptive Product Introduction
  • 14.8.3 Fuji Latex Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Foundation Consumer Healthcare
  • 14.9.1 Company Information
  • 14.9.2 Female Contraceptive Product Introduction
  • 14.9.3 Foundation Consumer Healthcare Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Ferring Pharmaceuticals
  • 14.10.1 Company Information
  • 14.10.2 Female Contraceptive Product Introduction
  • 14.10.3 Ferring Pharmaceuticals Female Contraceptive Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Bayer
• 14.12 Ansell
• 14.13 Allergan

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Female Contraceptive market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Female Contraceptive market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Female Contraceptive Devices
Female Contraceptive Drugs

Segmented by End User/Segment
Online Stores
Retail Outlets

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva Pharmaceuticals
Reckitt Benckiser
Pfizer
Okamoto Industries
Merck
Lupin Pharmaceuticals
Janssen Pharmaceuticals
Fuji Latex
Foundation Consumer Healthcare
Ferring Pharmaceuticals
Bayer
Ansell
Allergan